Documentos relacionados

1. Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials.
2. Are changes in the blood count clinically useful marker of azathioprine dose?
3. Progress and challenges in the biofoundry of immunosuppressants: From process to practice.
4. Influence of the Photodegradation of Azathioprine on DNA and Cells.
5. Association of ITPA gene polymorphisms with adverse effects of AZA/6-MP administration: a systematic review and meta-analysis.
6. Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
7. Thiopurine Therapy for Inflammatory Bowel Disease During Pregnancy Is Not Associated with Anemia in the Infant.
8. Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays.
9. Prediction of Thiopurine Metabolite Levels Based on Haematological and Biochemical Parameters.
10. Febuxostat as a novel option to optimize thiopurines' metabolism in patients with inadequate metabolite levels.